drugset / Trial / NCT00300742

Topiramate for the Treatment of Alcohol Dependent Binge-Eating Disordered Individuals

NCT00300742

Phase 2 Completed 5 enrolled University of Virginia
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to test the feasibility of using topiramate to reduce binge eating and drinking episodes in alcohol dependent individuals with comorbid binge eating disorder.

Timeline

Start
2006-03
Primary completion
2008-07
Completion
2008-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Topiramate Small molecule 300 mg